These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 25775905)
1. [Familial hypercholesterolemia due to a new mutation in the low density lipoprotein receptor gene]. Korneva VA; Bogoslovskaia TIu; Kuznetsova TIu; Mandel'shtam MIu; Vasil'ev VB Klin Med (Mosk); 2014; 92(7):49-53. PubMed ID: 25775905 [TBL] [Abstract][Full Text] [Related]
2. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients. Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841 [TBL] [Abstract][Full Text] [Related]
3. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Saavedra YG; Dufour R; Davignon J; Baass A Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291 [TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease. Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937 [TBL] [Abstract][Full Text] [Related]
7. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population. Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676 [TBL] [Abstract][Full Text] [Related]
8. [Familial hypercholesterolemia in Tunisia]. Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis. Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872 [TBL] [Abstract][Full Text] [Related]
14. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family. Lin J; Wang LY; Liu S; Wang XM; Yong Q; Yang Y; DU LP; Pan XD; Wang X; Jiang ZS Chin Med J (Engl); 2010 May; 123(9):1133-8. PubMed ID: 20529551 [TBL] [Abstract][Full Text] [Related]
15. Genetics of familial hypercholesterolemia. Brautbar A; Leary E; Rasmussen K; Wilson DP; Steiner RD; Virani S Curr Atheroscler Rep; 2015 Apr; 17(4):491. PubMed ID: 25712136 [TBL] [Abstract][Full Text] [Related]
16. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia. Chiou KR; Charng MJ Am J Cardiol; 2010 Jun; 105(12):1752-8. PubMed ID: 20538126 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of familial hypercholesterolaemia in Western Australia. Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975 [TBL] [Abstract][Full Text] [Related]
18. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes. Damgaard D; Jensen JM; Larsen ML; Soerensen VR; Jensen HK; Gregersen N; Jensen LG; Faergeman O Atherosclerosis; 2004 Dec; 177(2):415-22. PubMed ID: 15530918 [TBL] [Abstract][Full Text] [Related]
19. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family. Garcia-Garcia AB; Ivorra C; Martinez-Hervas S; Blesa S; Fuentes MJ; Puig O; Martín-de-Llano JJ; Carmena R; Real JT; Chaves FJ Atherosclerosis; 2011 Oct; 218(2):423-30. PubMed ID: 21868016 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis. Di Taranto MD; D'Agostino MN; Fortunato G Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]